Organisation paid for research Program year 2024 Source: CMS Open Payments

Integrated Clinical Research, LLC

Neither a doctor nor a teaching hospital

Research payments

$192,033

41 payments

Through program year 2024, Integrated Clinical Research, LLC is reported as receiving $192,033 in research payments, across 41 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2024	Research	$700	1
2023	Research	$7,612	4
2019	Research	$183,721	36

Breakdown

Who paid Research payments · program years 2019–2024

AbbVie, Inc. $172,296 34 payments
Perrigo Company plc $11,425 2 payments
Arcutis Biotherapeutics, Inc. $8,312 5 payments

Studies the money was for Research payments · program years 2019–2024

M16-766 $102,183 17 payments
M16-045 $61,114 16 payments
Bioequivalence study between Perrigo's product and Epiduo Forte Gel $11,425 2 payments
M16-046 $9,000 1 payment
A Phase 3, Multicenter, Open-Label Extension Study of the Long-Term Safety of ARQ-151 Cream 0.15% and ARQ-151 Cream 0.05% in Subjects with Atopic Dermatitis $4,212 3 payments
A Phase 3, 4-Week, Parallel Group, Double Blind, Vehicle-Controlled Study of the Safety and Efficacy of ARQ-151 Cream 0.15% Administered QD in Subjects with Atopic Dermatitis $4,100 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.